Ticker > Company >

Indrayani Biotech share price

Indrayani Biotech Ltd.

BSE: 526445 SECTOR: Floriculture  16k   36   1

35.40
-0.66 (-1.83%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 36.74

Today's Low

₹ 35

52 Week High

₹ 99.7

52 Week Low

₹ 35

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

161.2 Cr.

Enterprise Value

219.53 Cr.

No. of Shares

4.55 Cr.

P/E

286.87

P/B

2.98

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  11.88

CASH

0.26 Cr.

DEBT

58.6 Cr.

Promoter Holding

33.4 %

EPS (TTM)

₹  0.12

Sales Growth

-16.32%

ROE

3.21 %

ROCE

7.99%

Profit Growth

-71.18 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-16.32%
3 Year43.69%
5 Year∞%

Profit Growth

1 Year-71.18%
3 Year28.74%
5 Year96.14%

ROE%

1 Year3.21%
3 Year12.68%
5 Year-15.2%

ROCE %

1 Year7.99%
3 Year12.16%
5 Year-2.83%

Debt/Equity

1.1627

Price to Cash Flow

6.18

Interest Cover Ratio

1.6063

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 33.40 15.06
Jun 2024 33.48 15.02
Mar 2024 33.57 14.98
Dec 2023 33.63 0.00
Sep 2023 44.84 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 43.6896187624184% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 87.8753 days.

 Limitations

  • The company has a low EBITDA margin of -4.25644269517264% over the past 5 years.
  • The company is trading at a high PE of 286.87.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 16.01 13.69 15.8 10.79 9.51
Total Expenditure 14.71 12.36 14.79 9.81 8.07
Operating Profit 1.3 1.33 1.01 0.98 1.44
Other Income 0.09 0.08 3.45 1.03 0.89
Interest 0.62 0.78 2.47 1.52 1.89
Depreciation 0.37 0.37 0.36 0.32 0.32
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.41 0.26 1.62 0.17 0.13
Tax 0 0 1.55 0.04 0.03
Profit After Tax 0.41 0.26 0.07 0.13 0.1
Adjusted EPS (Rs) 0.12 0.06 0.02 0.03 0.02

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0.5 21.01 57.99 74.48 62.32
Total Expenditure 0.66 25.68 51.75 65.76 56.52
Operating Profit -0.15 -4.67 6.24 8.72 5.8
Other Income 0 0.26 0.22 0.64 3.62
Interest 0.05 1.97 1.89 2.85 4.96
Depreciation 0 0.4 0.34 0.93 1.45
Exceptional Items 0 -4.11 0 -0.5 0
Profit Before Tax -0.21 -10.89 4.23 5.08 3.01
Tax 0 0 0 0.02 1.55
Net Profit -0.21 -10.89 4.23 5.06 1.46
Adjusted EPS (Rs.) -0.56 -3.18 1.23 1.48 0.32

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.64 34.23 34.23 43.48 45.54
Total Reserves -4.5 -14.28 -10.05 7.67 8.98
Borrowings 0.69 8.15 6.79 9.76 14.88
Other N/C liabilities 0 0.01 0.01 6.33 5.09
Current liabilities 0.39 11.73 18.46 33.06 51.52
Total Liabilities 0.22 39.85 49.43 100.3 126.01
Assets
Net Block 0 15.11 15.33 23.81 21.66
Capital WIP 0 13.72 13.22 12.72 18.03
Intangible WIP 0 0 0 0 0
Investments 0 0.19 0.19 7.99 9.56
Loans & Advances 0 0.47 2.03 6.46 5.26
Other N/C Assets 0 1.33 0.68 0 0
Current Assets 0.22 9.04 17.99 49.33 71.5
Total Assets 0.22 39.85 49.43 100.3 126.01
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.21 -10.89 4.23 5.06 3.01
Adjustment 0.05 4.47 2.21 4.18 6.23
Changes in Assets & Liabilities 0.23 6.94 -2.97 -0.91 16.85
Tax Paid 0 0 0 0 0
Operating Cash Flow 0.08 0.52 3.47 8.33 26.09
Investing Cash Flow 0 -0.56 0.59 -14.09 -7.26
Financing Cash Flow 0 -0.73 -3.23 4.93 -19.19
Net Cash Flow 0.08 -0.78 0.82 -0.83 -0.36

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 44.84 33.63 33.57 33.48 33.40
g swaminathan . - - 9.09 9.09 9.09
i umasundari . - - 4.61 4.61 4.61
jothi ramesh . - - 2.31 2.31 2.31
m ramesh . - - 2.31 2.31 2.31
s i dinesh kumar . - - 1.54 1.54 1.54
s indirakumar . - - 4.61 4.61 4.61
sayee sundar kasiraman 7.69 5.78 5.78 5.78 5.78
thirumeni thiruselvaraja ... - - 1.85 1.81 1.76
v agathiyan . - - 1.47 1.43 1.39
g swaminathan 12.10 9.09 - - -
i umasundari 6.13 4.61 - - -
jothi ramesh 3.07 2.31 - - -
m ramesh 3.07 2.31 - - -
s i dinesh kumar 2.05 1.54 - - -
s indirakumar 6.13 4.61 - - -
thirumeni thiruselvaraja 2.56 1.88 - - -
v agathiyan 2.05 1.50 - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 55.16 66.37 66.43 66.52 66.60
ajitkumar c patel 3.21 - 2.42 2.85 2.85
dheeraj kumar lohia - - - - 2.05
jayaseelan singaravelu - - - 10.14 10.00
llp 0.13 0.21 0.21 0.23 0.25
malarvannan subashini - - 2.33 2.33 2.33
next orbit ventures fund 13.11 7.58 6.75 4.07 2.53
r raja . 3.16 - 2.37 2.37 1.12
rajasthan global securiti... - - - 2.73 3.06
s prakash - - 1.71 1.71 1.71
sridhar muthuraman - - - 2.20 2.20
geetha kannan - - - 1.10 -
sridhar - - 2.20 - -
bougainvillea investments... 1.84 1.32 - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Indrayani Biotech informs about disclosure 17 Dec, 11:01 AM Indrayani Biotech informs about outcome of board meeting 15 Nov, 10:32 AM Indrayani Biotech informs about certificate 14 Oct, 5:23 PM Indrayani Biotech - Quaterly Results 14 Aug, 7:41 PM Indrayani Biotech - Quaterly Results 30 May, 11:59 PM Indrayani Biotech - Quaterly Results 30 May, 11:59 PM Indrayani Biotech informs about disclosure 19 Feb, 3:27 PM Indrayani Biotech informs about newspaper publications 14 Feb, 11:51 AM Indrayani Biotech - Quaterly Results 10 Feb, 9:59 PM Indrayani Biotech informs about clarification 22 Jan, 12:19 PM Indrayani Biotech informs about newspaper advertisement 17 Jan, 3:20 PM Indrayani Biotech informs about loss of share certificate 2 Dec, 2:31 PM Indrayani Biotech informs about loss of share certificate 2 Dec, 2:17 PM Indrayani Biotech’s arm disinvests 51% stake in India Home Health Care 30 Aug, 5:15 PM Indrayani Biotech’s arm invests in Kniss Laboratories 26 Aug, 12:57 PM Indrayani Biotech - Quaterly Results 11 Aug, 9:40 PM Indrayani Biotech informs about outcome of the board meeting 15 Jun, 10:05 AM Indrayani Biotech - Quaterly Results 15 Jun, 12:04 AM Indrayani Biotech - Quaterly Results 15 Jun, 12:04 AM Indrayani Biotech - Quaterly Results 15 Jun, 12:04 AM Indrayani Biotech informs about board meeting 7 Jun, 4:58 PM Indrayani Biotech informs about certificate 28 Apr, 12:12 PM Indrayani Biotech’s arm to invest in Kniss Laboratories 14 Apr, 9:35 AM Indrayani Biotech informs about certificate 7 Jan, 3:29 PM Indrayani Biotech’s food and hospitality division bags order from Gautam Buddha University 3 Jan, 2:06 PM Indrayani Biotech’s arm acquires 51% stake in HIPL 8 Dec, 10:36 AM Indrayani Biotech informs about loss of share certificate 26 Nov, 12:22 PM Indrayani Biotech’s arm acquires 51% stake in IHHCPL 24 Nov, 10:57 AM Indrayani Biotech acquires 51% stake in Matrix Boilers 15 Nov, 9:46 AM Indrayani Biotech - Quaterly Results 14 Nov, 12:00 PM Indrayani Biotech informs about certificate 11 Oct, 4:52 PM Indrayani Biotech’s Food and Hospitality division bags order from Indian Institute of Technology 20 Aug, 10:30 AM Indrayani Biotech enters into MoU with Dindigul Farm Product 20 May, 9:52 AM Indrayani Biotech informs about disclosure 17 May, 11:02 AM Indrayani Biotech informs about updates 15 Mar, 4:50 PM Indrayani Biotech commences operations of Boiler division in association with Matrix Boilers 15 Mar, 3:59 PM Indrayani Biotech informs about closure of trading window 7 Jul, 12:56 PM Indrayani Biotech informs about price verification letter 3 Jun, 3:15 PM Indrayani Biotech incorporates WOS company 2 Nov, 9:52 AM Indrayani Biotech - Quaterly Results 29 Aug, 5:26 PM Indrayani Biotech informs about confirmation certificate 23 Jul, 4:00 PM

Indrayani Biotech Stock Price Analysis and Quick Research Report. Is Indrayani Biotech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indrayani Biotech has a PE ratio of 286.871961102107 which is high and comparatively overvalued .

  • Share Price: - The current share price of Indrayani Biotech is Rs 35.4. One can use valuation calculators of ticker to know if Indrayani Biotech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indrayani Biotech has ROA of 1.288 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indrayani Biotech has a Current ratio of 1.3878 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indrayani Biotech has a ROE of 3.2119 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Indrayani Biotech has a D/E ratio of 1.1627 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Indrayani Biotech has an Inventory turnover ratio of 32.9083 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Indrayani Biotech has reported revenue growth of -16.3224 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Indrayani Biotech for the current financial year is 9.30725858987155 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indrayani Biotech is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Indrayani Biotech
X